secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001140361-25-034845
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Grace Therapeutics shareholders elect 5 directors, approve executive pay and KPMG auditor at annual meeting
--------------------------------------------------------------------------------

- Five director nominees elected: Vimal Kavuru, A. Brian Davis, Prashant Kohli, S. George Kottayil, Edward Neugeboren; votes for ranged 6.29M-6.30M.
- Advisory vote on named executive officer compensation passed: 6,178,757 for, 74,002 against, 75,696 abstain, 1,598,490 broker non-votes.
- Ratification of KPMG as independent auditor for FY2026 approved: 7,797,832 for, 127,248 against, 1,865 abstain, no broker non-votes.
- Approximately 57.32% of outstanding shares (7,926,945 of 13,828,562) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000114036125034845/0001140361-25-034845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000114036125034845/ef20055483_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-034845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer